P. Schoenfeld Asset Management (PSAM)’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500,000	Closed	-$5.13M	–	163
2023 Q1	$5.13M	Hold	500,000	–	–	0.45%	43
2022 Q4	$5.03M	Hold	500,000	–	–	0.45%	45
2022 Q3	$4.93M	Hold	500,000	–	–	0.27%	69
2022 Q2	$4.87M	Hold	500,000	–	–	0.29%	86
2022 Q1	$4.87M	Buy	+500,000	New	+$4.85M	0.24%	109

P. Schoenfeld Asset Management (PSAM)'s ORIA Position: Q2 2023 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 500,000 shares — an estimated $5.13M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in ORIA in Q1 2022 and held it in 5 quarters. The position peaked at $5.13M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

P. Schoenfeld Asset Management (PSAM) reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
P. Schoenfeld Asset Management (PSAM) sold 500,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $5.13M.
P. Schoenfeld Asset Management (PSAM) first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q1 2022 and held it in 5 quarters.
P. Schoenfeld Asset Management (PSAM)'s Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $5.13M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2023, filed 11 Aug 2023.